Accelerate adoption with robust, pragmatic economic evidence
We know how hard it is to generate the right evidence at the right time, so we offer a range of services suited to your needs.
Get in touch
Published in
The challenge
94% of investors believe demonstrating return on investment is critically important, yet 44% of digital health solutions have no published evidence to back their claims. That's the gap we help close.
What we do
Economic evidence strategy
Understand what evidence is required for your solution aligned with customers' and HTA bodies' (e.g. NICE) expectations.
Economic modelling and evaluations
Demonstrate the return on investment and cost-effectiveness of your solution through economic modelling and evaluations. We conduct early economic modelling, budget impact analyses, cost-effectiveness analyses, cost-utility analyses, cost comparison analyses and cost-benefit analyses.
Economic evidence communication
Share your evidence in high-impact health economics and outcomes research journals, at leading HEOR conferences (e.g. ISPOR), or through white papers and independent reports tailored to payers and HTA bodies.
Case studies
View all case studiesEstimating cost savings from Microsoft AI's Diagnostic Orchestrator (MAI-DxO)
Advised on approach and methods to estimate cost savings from the newly developed MAI-DxO model. Estimated cost savings of up to 70%, due to the impact on physician visits and tests performed.
Read the case study: Estimating cost savings from Microsoft AI's Diagnostic Orchestrator (MAI-DxO)Proving the business case for a UK population health tool by modelling cost savings
Developed a user-friendly cost calculator to quantify the financial impact of the tool, enabling cost-saving analysis to be localised for any NHS ICB. Demonstrated a potential net cost reduction of £2.7 million with the NHS.
Read more: Proving the business case for a UK population health tool by modelling cost savingsEvaluating the economic effectiveness of Appt Health’s tool to boost Cervical Screening and Lung Cancer Screening in England (ongoing)
We are evaluating Appt Health's intervention with a planned 460,000+ patients, 150+ practices, and seven Cancer Alliances in England after receiving funding from the SBRI NHS Cancer Programme.
Read more: Evaluating the economic effectiveness of Appt Health’s tool to boost Cervical Screening and Lung Cancer Screening in England (ongoing)